Connect with us

Opinion

The right to health and access to medicinal cannabis in Portugal: an unfulfilled constitutional promise

Published

em

Listen to this article

On 31 May 2025, the Cannabis March took place in Lisbon, where people from various regions of the country gathered to demand the legalisation of cannabis, defending the right to grow up to four plants per person at home. This civic movement once again put an essential issue on the public agenda: fair and equitable access to cannabis for medicinal purposes.

In Portugal, the right to health is enshrined in the Constitution of the Portuguese Republic in article 64, guaranteeing all citizens protection and equal access to health care. However, this fundamental right clashes with the concrete reality of many Portuguese people when it comes to access to medicinal cannabis.

Although cannabis for medicinal purposes has been legal since 2018, its acquisition is limited to products authorized by Infarmed, exclusively available in pharmacies and at high prices. These products are not subsidized by the State, making them inaccessible to many patients, especially those on low incomes. Herein lies the paradox: there is a recognized right and a legal therapeutic substance, but real access to it is, for many, a mirage.

Faced with this economic exclusion, some patients resort to self-cultivation of cannabis as a last resort to alleviate pain or treat chronic conditions. However, even in these cases, Portuguese law considers cultivation a crime, punishable under Decree-Law 15/93. The courts have systematically rejected arguments based on the right to health or the right to resistance (art. 21 of the Portuguese Constitution), based on the existence of legal access routes — even though these are economically unviable and very limited in terms of options for certain pathologies.

The question that arises is this: what value does a fundamental right have if it is not guaranteed to everyone, regardless of their economic status? When access to healthcare is conditioned by the ability to pay, we are faced with a constitutional fallacy.

What is required is not the indiscriminate liberalization of cultivation, but rather a State that ensures the effectiveness of the rights it proclaims.

If medicinal cannabis is recognised as a treatment, then equal access must be guaranteed, through co-payment by the NHS or mechanisms that protect the most vulnerable.

In a democracy worthy of the name, fundamental rights cannot be class privileges. The right to health, enshrined in our Constitution, must be experienced as a concrete reality and not just a formal promise.

Otherwise, the Constitution becomes a dead letter and the poorest continue to pay the price of legal hypocrisy.

 

____________________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]

____________________________________________________________________________________________________

What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!

Leonardo Sousa
More posts
Click here to comment
Subscribe
Notify of

0 Comments
Inline feedback
View all comments
Advertise with us!


Watch the Documentary "Patients" by Laura Ramos

Documentary Patients Laura Ramos help us grow

Mais recentes

Press Releases4 days ago

GNR Faro | Vilamoura – Seizure of more than 700 products in a cannabis store

The Faro Territorial Command, through the Loulé Territorial Detachment, carried out an operation on July 8th...

Science4 days ago

Systematic review and meta-analysis demonstrate the potential of CBD in reducing seizure frequency in Epilepsy

Epilepsy, as a chronic neurological disease, affects a substantial number of individuals globally, with a significant subset...

National6 days ago

Portugal: New cannabis seizure in Grândola exposes yet another illegal trafficking operation disguised as a medicinal facility

As part of the operation to combat drug trafficking, the Judicial Police (PJ) seized more than 2.200 kilos today...

International7 days ago

North Macedonia: Government to review company licenses after seizing cannabis destined for the illicit market

“All licenses granted to companies processing cannabis for medicinal purposes will be reviewed.” The government of North Macedonia...

National7 days ago

Portugal: New Operation “Ortiga” seizes 2 tons of cannabis and arrests two foreign citizens

The investigation that the Judiciary Police began in May and which targets medicinal cannabis companies in Portugal had today...

International1 weeks ago

Thailand: New cannabis regulations aren't as bad as they seem. Here's what's really at stake in the country

The Thai government recently announced its intention to review its cannabis legislation, with the aim of limiting...

International1 weeks ago

Lorraine Nolan chosen to head European Drugs Agency (EUDA)

The Executive Assembly of the European Drugs Agency (EUDA) has appointed Irishwoman Lorraine Nolan to take up the position of Director...

Events1 weeks ago

Cannabis Europa: “Doctors continue to leave medical school without having learned about the endocannabinoid system”

The phrase is from Niall Ivers, co-founder of Cantourage, and reveals a systemic problem in the medicinal cannabis sector in...

Analysis2 weeks ago

Hungary: New drug policy includes zero tolerance and hate campaigns

The Hungarian government, in power for 15 years, has consistently used marginalized groups as scapegoats for its problems,...

Science2 weeks ago

SOMAÍ and Universidade Lusófona publish peer-reviewed study to improve practices in the production of full-spectrum cannabis oils

SOMAÍ Pharmaceuticals, a multinational operator with EU-GMP certification, through a partnership with Universidade Lusófona, has published a study...